Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

Medicare beneficiaries with common chronic health conditions who complied with PAP therapy saw reduced costs, according to a new study.

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...

DIABETES mellitus has emerged as one of the leading causes of death ... In response, the Tanzanian government has launched initiatives to improve access to treatment and encourage healthier lifestyles ...

U.S. stock markets have been facing severe volatility since the beginning of 2025. Market participants are concerned about the forward trajectory of both inflation and interest rates. Moreover, ...

Micronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

CMAJ Study Highlights Recipe for Healthy AgingA review article published in Canadian Medical Association Journal summarizes ...

Promoted by nutrition pros and research, the DASH diet is at the top of the diet charts. Learn why this is a smart eating plan and how it could benefit more than just your blood pressure.

CPAP therapy, the traditional standard for obstructive sleep apnea (OSA), is universally despised by patients, resulting in abysmally low compliance rates. Recent studies show it also fails to ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...